Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase II Study of Enzalutamide (NSC# 766085) for Patients with Androgen Receptor Positive Salivary CancersCIRB: Adult CIRB - Late Phase EmphasisLead Group: AllianceStatus: ActiveReview Status: Available to Open
